[Hepatic adenomas and oral contraceptives].
D006528:Carcinoma, Hepatocellular / Q000139:chemically induced*; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D004338:Drug Combinations; D005260:Female; D006406:Hematoma / Q000139:chemically induced; D006801:Humans; D008113:Liver Neoplasms / Q000139:chemically induced*; D008234:Lynestrenol / Q000009:adverse effects*; D008656:Mestranol / Q000009:adverse effects*; D008875:Middle Aged; D010382:Peliosis Hepatis / Q000139:chemically induced
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D004338:Drug Combinations; C002746:Noracycline; D008656:Mestranol; D008234:Lynestrenol
"Adenomas hepáticos y anticonceptivos orales".